Document Type
Article
Publication Title
Future oncology
First Page
25
Last Page
49
DOI
10.1080/14796694.2024.2408909
Publication Date
1-1-2025
Recommended Citation
Voorhees, Peter M; Sborov, Douglas W; Laubach, Jacob; Kaufman, Jonathan L; Reeves, Brandi; Rodriguez, Cesar; Silbermann, Rebecca; Costa, Luciano J; Anderson, Larry D; Nathwani, Nitya; Shah, Nina; Bumma, Naresh; Efebera, Yvonne A; Holstein, Sarah A; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M; Orlowski, Robert Z; Shain, Kenneth H; Cowan, Andrew J; Dinner, Shira; Gries, Katharine S; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S; Usmani, Saad Z; and Richardson, Paul G, "A plain language summary of the final analysis of the GRIFFIN study of daratumumab plus lenalidomide, bortezomib, and dexamethasone for people with newly diagnosed multiple myeloma." (2025). Oncology Articles. 24.
https://scholarlyworks.ohiohealth.com/oncology-articles/24